In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ ... In 2023, the healthcare industry made up around 17.6% of the US economy, up 17.4% from 2022.

a half-decade historical view may miss recent innovations or disruptive industry trends. United Therapeutics’s annualized revenue growth of 21.9% over the last two years is above its five-year ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

Learn more about whether PTC Therapeutics, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...

D Systems Corporation (NYSE:DDD) announced today its financial results for the fourth quarter and full year ended December 31, 2024. Full-year 2024 ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ ... In 2023, the healthcare industry made up around 17.6% of the US economy, up 17.4% from 2022. The ...

We at StockStory place the most emphasis on long-term growth, but within healthcare, a half-decade historical view may miss recent innovations or disruptive industry trends. United Therapeutics ...

United Therapeutics achieved record revenue growth in 2024, marking the third consecutive year of such performance with a 24% increase over 2023. The company maintains industry-leading gross ...

United Therapeutics, which belongs to the Zacks Medical - Drugs industry, posted revenues of $735.9 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.46%.

In the past year, shares of United Therapeutics have surged 57.6% against the industry’s 15.4% decline. Image Source: Zacks Investment Research Research and development expenses were $133.8 ...

The stock market is waiting on a follow through day. Miami's eMerge Americas conference may provide some surprise energy for ...